Chemotherapy of Chagas disease

Current Pharmaceutical Design

Volumn 8, Issue 4, 2002, Pages 287-295

  Urbina, Julio A ^a  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,4 DIFLUOROPHENYL) 1 [3 [2 [4 (2,2,3,3 TETRAFLUOROPROPOXY)PHENYL]VINYL] 1,2,4 TRIAZOL 1 YL] 3 (1,2,4 TRIAZOL 1 YL) 2 PROPANOL; 2 [2 (2,4 DIFLUOROPHENYL) 2 HYDROXY 1 METHYL 3 (1H 1,2,4 TRIAZOL 1 YL)PROPYL] 4 [4 (2,2,3,3 TETRAFLUOROPROPOXY)PHENYL] 1,2,4 TRIAZOL 3(2H) ONE; ALKYLLYSOPHOSPHOLIPID; ALLOPURINOL; ANTIPARASITIC AGENT; BENZNIDAZOLE; CATHEPSIN L; CRUZIPAIN; CYSTEINE PROTEINASE INHIBITOR; CYTOCHROME P450; ENZYME INHIBITOR; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; ITRACONAZOLE; KETOCONAZOLE; METHYLTRANSFERASE INHIBITOR; MEVINOLIN; MICROBIAL ENZYME; NIFURTIMOX; NITROFURAN; NITROIMIDAZOLE; PHOSPHATIDYLCHOLINE; POSACONAZOLE; PYROPHOSPHATE; PYRROLE DERIVATIVE; STEROL; STEROL 14ALPHA DEMETHYLASE; TERBINAFINE; TRIAZOLE DERIVATIVE; TRYPANOTHIONE; UNINDEXED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ANTIPROTOZOAL ACTIVITY; CHAGAS DISEASE; CHEMOTHERAPY; CHRONIC DISEASE; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DRUG EFFICACY; DRUG MECHANISM; DRUG RESISTANCE; DRUG SCREENING; DRUG STRUCTURE; DRUG TARGETING; DRUG TOXICITY; EXPERIMENTAL INFECTION; HUMAN; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PATIENT SELECTION; PHOSPHOLIPID SYNTHESIS; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SKIN DISEASE; STEROL SYNTHESIS; TREATMENT FAILURE; TREATMENT PLANNING; TRYPANOSOMA CRUZI; VOMITING;

ANIMALS; CHAGAS DISEASE; HUMANS; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 0036234361     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612023396177     Document Type: Review

References (127)